evaluation of lisedexamfetamine dimesylate in tratment of binge eating disorder alone and in combination with topiramte in edults
Phase 3
Recruiting
- Conditions
- Binge eating disorder.Binge eating disorderF50-81
- Registration Number
- IRCT20230910059396N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Participants aged 18-55 years old meeting the diagnostic criteria for BED according to DSM-5
Exclusion Criteria
Posing other major psychiatric disorders assessed by psychiatris (anxiety ,depression,..)
Posing physical disease like cardiovascular diseases, thyroid disturbances or gastrointestinal diseases
known sensitivity to LDX or TPM.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Binge eating score. Timepoint: At first and 3months after. Method of measurement: Bing eating scale of gormally.
- Secondary Outcome Measures
Name Time Method Body mass index. Timepoint: First qnd 3months after treatment. Method of measurement: Meter and wieght.